Skip to main content
OpenTrials
Completed

NCT Number: NCT05493787

Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot

The purpose of this study is to test whether messages that make it easy to schedule a flu shot appointment will increase flu shot rates in patients without an upcoming appointment. The study will also test which message versions and message timing are most effective for increasing flu vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geisinger Clinic

Danville, Pennsylvania, 17822, United States

About this study

The CDC recommends a flu vaccination to everyone aged 6+ months, with rare exception; almost anyone can benefit from the vaccine, which can reduce illnesses, missed work, hospitalizations, and death. Past work from the study team focused on encouraging flu shots for patients with upcoming appointments. However, many patients in the health system do not have any appointments during flu season.

Eligible patients without an upcoming appointment will be randomized to a passive control group (no message), an active control group (a basic message stating that the patient can get a flu shot at Geisinger) or one of several other messages informed by behavioral science ("ease", "waiting for you", "protect yourself - rare outcomes", or "protect yourself - frequent outcomes"). Patients will be randomly assigned to one of several message send dates. Messages sent via patient portal, short message service (SMS) text, email, and/or another modality, will include a link redirecting patients to a page where they can self-schedule a flu shot.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Included in one or both of the following two base patient lists:
  • Geisinger patient portal flu outreach list for Fall 2022
  • A list of patients obtained from Geisinger's Phenomics and Clinical Data Core (PACDC). This list will include active Geisinger patients (all patients on this list attended at least one primary care appointment at Geisinger between 10/1/2008 and 4/13/2022, and either had a Geisinger primary care provider assigned as of April 2022, or were in the Electronic Health Record [EHR] since at least September 2021 and had at least one encounter in 2020-2022).
  • Aged 18 or older as of October 2022
  • Has had a Geisinger encounter in the last 2 years as of October 2022
  • Either of the following, as of October 2022:
  • Has a Geisinger PCP assigned in the Community Medicine, Pediatrics, or Internal Medicine service line
  • In the last 2 years, has completed an appointment in a Geisinger specialty on a list of specialties approved by system leadership for flu shot communications
  • Has not received a flu-shot during the 2022-23 flu season as of ~1 week prior to the message date (timeline may be slightly different, depending on data pull logistics), according to the Electronic Health Record (EHR)
  • Does not have a scheduled in-person primary care or in-person flu-shot-eligible specialty appointment in the 12 weeks following their assigned message send date, as of ~1 week prior to the message date (timelines may be slightly different, depending on data pull logistics or clinical guidance)
  • As of this writing, the team plans to define a flu-shot-eligible specialty appointments as appointments in departments that have historically documented or administered flu vaccine. However, this approach may change slightly based on changing clinical guidance.

Exclusion criteria

  • The CMSL/Marketing list will include patients in Geisinger's 65Forward or Community Care populations. If necessary due to logistical constraints, we may exclude these 65Forward and/or Community Care patients from our study.
  • Cannot be contacted via the communication modality being used in the study (e.g., patient portal, SMS), e.g., due to insufficient/missing contact information in the EHR or because they opted out
  • Has an allergy to flu vaccines according to any EHR allergy table known to the study team
  • Has a health maintenance modifier indicating they are permanently discontinued from receiving a seasonal flu shot
  • Is on a list of dismissed patients

Treatment and study plan

Reminder

Behavioral

Patient portal, SMS, email, and/or another modality

Primary outcomes

  1. Number of Patients Who Self-scheduled a Flu Shot

    Time frame: Within 4 weeks of message send date

    Patient self-schedules a flu vaccine appointment through the patient portal.

    This outcome measures whether the patient schedules an appointment within 4 weeks of the send date, but the appointment can occur more than 4 weeks past the send date.

Secondary outcomes

  1. Flu Vaccination

    Time frame: Within 4 weeks of message send date

    Number of patients who received a flu vaccine

Other outcomes

  1. High Confidence Flu Diagnosis

    Time frame: Up to 7 months

    Patient received a flu diagnosis via a positive PCR/antigen/molecular test (yes/no) during the 2022-23 flu season (from the patient's message send date through April 30, 2023).

  2. "Likely Flu" Diagnosis

    Time frame: Up to 7 months

    Received a "high confidence flu" diagnosis (with positive polymerase chain reaction [PCR]/antigen/molecular test) and/or "likely flu" diagnosis (as assessed via International Classification of Disease [ICD] codes or Tamiflu administration or positive PCR/antigen/molecular test) (yes/no) during the 2022-23 flu season (from the patient's message send date through April 30, 2023).

    Note that "likely flu" is a superset of the "high confidence flu" diagnoses.

  3. Flu Complications

    Time frame: Up to 10 months

    Diagnosed with flu-related complications (yes/no) from the patient's message send date through July 31, 2023.

  4. ER Visits

    Time frame: Up to 10 months

    Number of ER visits from the patient's message send date through July 31, 2023.

  5. Hospitalizations

    Time frame: Up to 10 months

    Number of hospitalizations from the patient's message send date through July 31, 2023.

  6. COVID-19 Vaccination Rates

    Time frame: Up to 7 months

    Received at least one COVID-19 vaccination (yes/no) during the 2022-23 flu season (from the patient's message send date through April 30, 2023).

  7. Number of Patients Who Self-Scheduled a Flu Shot by Sex

    Time frame: Within 4 weeks of the message send date

    Patient self-schedules a flu vaccine through the patient portal This outcome measures whether the patient schedules an appointment within 4 weeks of the message send date, but the appointment can occur more than 4 weeks past the send date.

  8. Number of Patients Who Self-Scheduled a Flu Shot by Race

    Time frame: Within 4 weeks of the message send date

    Patient self-schedules a flu vaccine through the patient portal This outcome measures whether the patient schedules an appointment within 4 weeks of the message send date, but the appointment can occur more than 4 weeks past the send date.

  9. Number of Patients Who Self-Scheduled a Flu Shot by Ethnicity

    Time frame: Within 4 weeks of the message send date

    Patient self-schedules a flu vaccine through the patient portal This outcome measures whether the patient schedules an appointment within 4 weeks of the message send date, but the appointment can occur more than 4 weeks past the send date.

Sponsors and collaborators

Lead sponsor

Geisinger Clinic

Other

Collaborators

  • Massachusetts Institute of Technology
  • National Bureau of Economic Research, Inc.

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 9, 2022
Registry last updated
Dec 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.